Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

about

Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

Item

http://www.wikidata.org/entity/Q55708995

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

@en

Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

@nl

type

Item

label

Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

@en

Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

@nl

prefLabel

Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

@en

Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

@nl

P1476

Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

@en

P2093

Anete Trajman

http://www.w3.org/2001/XMLSchema#string

Draurio Barreira

http://www.w3.org/2001/XMLSchema#string

José Uereles Braga

http://www.w3.org/2001/XMLSchema#string

João Paulo Toledo

http://www.w3.org/2001/XMLSchema#string

Maria do Socorro Nantua Evangelista

http://www.w3.org/2001/XMLSchema#string

Ricardo Gadelha de Abreu

http://www.w3.org/2001/XMLSchema#string

Rosalia Maia

http://www.w3.org/2001/XMLSchema#string

P2860

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis.

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program.

Five-year assessment of time of sputum smears conversion and outcome and risk factors of tuberculosis patients in central iran.

Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment.

Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study.

Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon

Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resista

Predictors of delayed sputum smear and culture conversion among a Portuguese population with pulmonary tuberculosis.

P2888

s13104-018-3522-3

P304

414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13104-018-3522-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105177234

http://www.w3.org/2001/XMLSchema#string

P698

29954436

http://www.w3.org/2001/XMLSchema#string

P921

An Bhrasaíl

sputum

P932

6022340

http://www.w3.org/2001/XMLSchema#string